A*STAR biosensor rapidly detects Influenza A

A new biosensor with improved sensitivity can rapidly detect influenza viruses and may potentially help health professionals more accurately diagnose Influenza A. Read More »

Rotary International vows to support Pakistan-Afghanistan polio campaign

Rotary International said Friday it will guarantee its support to the Balochistan Emergency Operation Centre (EOC) for enhancing a polio vaccination campaign along the border of Pakistan and Afghanistan.Rotary representatives Asher Ali and Dr. Muhammad Hanif  met with EOC Coordinator Syed Saifur Rehman to voice their dissatisfaction concerning inadequate arrangements at the international transit point. The two Rotary representatives then gave their total support for the organization. Read More »

Pennsylvania officials find West Nile virus sample

The Pennsylvania Department of Environmental Protection (DEP) and Health Department have confirmed the year's first West Nile virus detection from a mosquito sample collected in Springettsbury Township, York County, on May 22.  Read More »

Anacor Pharmaceuticals names new executive vice president

Graeme Bell, who has more than 20 years of extensive global financial experience within the pharmaceutical industry, will be Anacor Pharmaceuticals Inc.’s new executive vice president and chief financial officer. Read More »

Scientists develop new vaccine for Streptococcus A

Scientists from Griffith University’s Institute for Glycomics recently created a novel combination vaccine that combines SpyCEP protein and an earlier vaccine called J8-DT and may effectively treat and eliminate Streptococcus A infections. Read More »

Avian influenza detrimental to global poultry industry

Rabobank recently published a report that analyzes how avian influenza has changed and challenged the global poultry industry, specifically in international trade. Read More »

Avian influenza quarantines end in two North Dakota counties

North Dakota's State Board of Animal Health recently concluded the highly pathogenic avian influenza (HPAI) H5 quarantines that stopped all transfer for poultry and poultry products within LaMoure and Dickey counties. Read More »

HPV vaccine successfully heat stabilized

According to a recent announcement from Soligenix Inc., the company has successfully applied its heat-stabilization technology to its human papillomavirus (HPV) vaccine. Read More »

ProBioGen advances Ebola vaccine to clinical trials

ProBioGen, a complex biologics creation and production specialist, recently announced that its researchers have created an investigational Ebola virus vaccine in its proprietary, continuous Muscovy duck AGE1.CR.pIX cell line that is now progressing into clinical trials. Read More »

Vitesse Biologics forms to speed therapeutic innovations

Mayo Clinic, Baxter Ventures and Velocity Pharmaceutical Development LLC, recently collaborated to form Vitesse Biologics LLC, which is specially structured to further speed and advance innovative therapeutics for oncology, immunology and hematology. Read More »

New Mexico reports year's first human West Nile virus case

The New Mexico Department of Health has reported that a 12-year-old girl living in Valencia County has been diagnosed with the state's first human case of West Nile virus for 2015. Read More »

Drug may halt HBV transmission during pregnancy

A study published in the June issue of the American Gastroenterological Association's Clinical Gastroenterology and Hepatology shows that telbivudine, an antiviral drug, may stop the transmission of hepatitis B virus (HBV) from the mother to the infant during pregnancy. The study involved 350 pregnant women with HBV. All of the women showed high viral loads of HBV within their bloodstreams during their second or third trimesters. Read More »

Latest update on Indiana HIV outbreak

According to the most recent update from the Indiana State Department of Health (ISDH), there are now 166 total HIV cases in the southeastern Indiana outbreak. Read More »

FDA responds to concerns over hepatitis C treatments

The United States Food and Drug Administration’s (FDA) Division of Antiviral Products in the Center for Drug Evaluation and Research (CDER) recently released a paper that addresses the public concerns toward the FDA’s recent approval of treatments for chronic hepatitis C. Read More »

Takeda consolidates US vaccine sites in Boston

Takeda Pharmaceutical Co. Ltd. recently announced that it will begin to consolidate the company’s Vaccine Business Unit (VBU) operations throughout the Boston and Cambridge area. Read More »

Biosantech to unveil Phase II HIV vaccine results

French pharmaceutical company Biosantech recently will soon unveil the latest results from its Phase II clinical study of a vaccine for HIV. Read More »

Quadrivalent seasonal influenza vaccine candidate advances to Phase 2 testing

VaxInnate Corp., a biotechnology company creating a novel vaccine technology platform, recently announced that it has started a double-blind, randomized, active comparator controlled Phase 2 study for a quadrivalent seasonal influenza vaccine candidate. Read More »

Immunity enzyme may fight off tuberculosis infection

The University of Texas (UT) Southwestern Medical Center said Tuesday that a recent study by its researchers has revealed how a specific immunity enzyme may protect the body from Mycobacterium tuberculosis (TB) infections. Read More »

Anti-Ebola virus activity found in 80 approved drugs

A team of scientists at the National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National Institutes of Health, recently announced that they have found antiviral activity against Ebola in 80 drugs that are currently licensed. Drugs that are already approved have received well-established safety profiles. Read More »

Visterra presents data from avian influenza treatment

Visterra Inc., a clinical-stage biotechnology company with a proprietary technology platform that identifies unique disease targets to create novel therapeutics to treat infectious diseases, recently presented its latest preclinical data for VIS410, a potential treatment for avian influenza’s deadly strain. Read More »